Overview

Lipoic Acid for Progressive Multiple Sclerosis (MS)

Status:
Recruiting
Trial end date:
2023-08-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if lipoic acid can preserve mobility and protect the brain in progressive forms of multiple sclerosis.
Phase:
Phase 2
Details
Lead Sponsor:
VA Office of Research and Development
Treatments:
Thioctic Acid